Abstract
Backgroud: COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054-62, 2020). While D-dimer is accepted as a disseminated intravascular coagulation marker, rotational thromboelastometry (ROTEM) also detects fibrinolysis (Wright FL et al. in Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg (2020). Available from https://pubmed.ncbi.nlm.nih.gov/32422349/ [cited 14 Jun 2020]; Schmitt FCF et al. in Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 9(1):19, 2019). We describe the ROTEM profile in severely ill COVID-19 patients and compare it with the standard laboratory coagulation test.
Methods: Adult patients diagnosed with COVID-19 admitted to the ICU were prospectively enrolled after Ethics Committee approval (HCB/2020/0371). All patients received venous thromboembolism prophylaxis; those on therapeutic anticoagulation were excluded. The standard laboratory coagulation test and ROTEM were performed simultaneously at 24-48 h after ICU admission. Sequential organ failure assessment (SOFA), disseminated intravascular coagulation (DIC) and sepsis-induced coagulopathy (SIC) scores were calculated at sample collection.
Results: Nineteen patients were included with median SOFA-score of 4 (2-6), DIC-score of 1 (0-3) and SIC-score of 1.8 (0.9). Median fibrinogen, D-dimer levels and platelet count were 6.2 (4.8-7.6 g/L), 1000 (600-4200 ng/ml) and 236 (136-364 10 9 /L), respectively. Clot firmness was above the normal range in the EXTEM and FIBTEM tests while clot lysis was decreased. There was no significant correlation between ROTEM or D-dimer parameters and the SOFA score.
Conclusion: In COVID-19 patients, the ROTEM pattern was characterized by a hypercoagulable state with decreased fibrinolytic capacity despite a paradoxical increase in D-dimer levels. We suggest that, in COVID-19 patients, the lungs could be the main source of D-dimer, while a systemic hypofibrinolytic state coexists. This hypothesis should be confirmed by future studies.
Keywords: COVID; Coagulation; Fibrinolysis; Thromboelastometry.
【저자키워드】 fibrinolysis, Coagulation, COVID, Thromboelastometry., 【초록키워드】 COVID-19, Risk factors, Mortality, lung, D-dimer, Sepsis, risk factor, Venous Thromboembolism, fibrinolysis, ICU, Laboratory, Coagulation, Coagulopathy, COVID-19 infection, clinical, Lungs, Wuhan, morbidity, Patient, ICU admission, Septic shock, Platelet, fibrinogen, SOFA, correlation, London, England, COVID-19 patients, Platelet count, Hypercoagulable state, marker, Disseminated intravascular coagulation, therapeutic anticoagulation, D-dimer level, Hypothesis, COVID-19 patient, Organ failure, hypercoagulable, normal range, coagulation test, SOFA score, Inpatient, retrospective cohort study, Severe COVID-19 Infection, thromboembolic, Sequential Organ Failure Assessment, Thromboembolic events, D-dimer levels, pilot study, Adult patients, fibrinolytic, high mortality, ethics committee, approval, severely ill COVID-19 patients, sample collection, intravascular coagulation, while, parameter, clot, sepsis-induced coagulopathy, Lancet, Thromboembolic event, Course, enrolled, performed, detect, median, characterized, calculated, occur, increase in, Adult patient, diagnosed with COVID-19, paradoxical, were excluded, with COVID-19, 【제목키워드】 COVID19, D dimer,